marine bioprospecting - Novel Drugs from the Sea


MarBiLeads seeks qualified agents for sales of licenses of MBL leads and follow up of licensees in the following regions: 

  • Europe 
  • North America 
  • South America 
  • Japan 
  • Central and Eastern Europe (CEE) and Commonwealth of Independent States (CIS) 
  • China 
  • India 

Candidate agents should document professional qualifications on university level, experience from the biotech and pharmaceutical industry as well as a relevant business network within the region. 

Candidates may be persons or companies. 

MarBiLeads licenses to offer: 

 The company lead compounds the chosen agents will market and offer for licensing are documented as follows: 

  • Proven in vitro antibacterial activity against a spectrum of multi-drug-resistant Gram negative and Gram positive pathogenic bacteria (clinical isolates). 
  • Proven in vitro anticancer activity against a panel of selected cancer cell lines. 
  • Third party verification of activity. 
  • Molecular structure. 
  • Possible scalable production process established.
  • Possible production process (pilot scale) described.

The financial terms for the license will consist of a combination of milestone payments during the development period and royalty from sales. 


Agencies will be exclusive for the region. 

Separate agreements may be entered in a region for the antibacterial and anticancer area. 

Agents will be compensated on revenue share basis based on milestone payments up to completion of clinical Phase IIa. 

Contact Ole-Martin Gulliksen: